ストックスクリーナーアプリを入手
5.68
7.34%
-0.45
アフターアワーズ：
5.50
-0.18
-3.17%
Meiragtx Holdings Plc (MGTX) 最新ニュース
MeiraGTx Holdings Signs New Lease in New York - TipRanks
MeiraGTx Holdings secures new lease, terminates old sublease - Investing.com
Is MeiraGTx Holdings (NASDAQ:MGTX) Using Debt Sensibly? - simplywall.st
MeiraGTx Reports Strategic Advances and Financial Results - TipRanks
Charles Schwab Investment Management Inc. Buys 12,961 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
Chardan Capital Forecasts MeiraGTx FY2026 Earnings - MarketBeat
MeiraGTx (NASDAQ:MGTX) Trading Down 2.4%Time to Sell? - MarketBeat
Chardan Capital Comments on MeiraGTx FY2026 Earnings - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Position Increased by Bank of New York Mellon Corp - Defense World
Chardan Capital Forecasts MeiraGTx FY2025 Earnings - Defense World
MeiraGTx Holdings: Gaining Regulatory Focus (NASDAQ:MGTX) - Seeking Alpha
MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future - Yahoo Finance
Reviewing MeiraGTx (NASDAQ:MGTX) and CRISPR Therapeutics (NASDAQ:CRSP) - Defense World
MeiraGTx (NASDAQ:MGTX) Given New $13.00 Price Target at Royal Bank of Canada - Defense World
MeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s Treatment - Insider Monkey
RBC Capital raises MeiraGTx stock price target to $13.00 By Investing.com - Investing.com Canada
RBC Capital raises MeiraGTx stock price target to $13.00 - Investing.com
RBC Raises Price Target on MeiraGTx Holdings to $13 From $11, Keeps Outperform, Speculative Risk - MarketScreener
When the Price of (MGTX) Talks, People Listen - news.stocktradersdaily.com
MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume – Here’s Why - Defense World
Top 10 AI News Updates Taking Wall Street By Storm - Insider Monkey
Plaudits For MeiraGTx And Its Parkinson’s AI Pact - insights.citeline.com
US$200M Deal Accelerates Phase 3 Gene Therapy for Parkinsons - Streetwise Reports
MeiraGTx Holdings plc's (NASDAQ:MGTX) 29% Price Boost Is Out Of Tune With Revenues - Simply Wall St
MGTX stock touches 52-week high of $7.9 amid market optimism - Investing.com
MeiraGTx Shares Soar After Joint Venture Deal With Hologen -March 13, 2025 at 03:31 pm EDT - Marketscreener.com
Top Midday Gainers -March 13, 2025 at 02:24 pm EDT - Marketscreener.com
MGTX’s price-to-sales ratio: A comparative analysis with its peers - US Post News
MeiraGTx Holdings plc SEC 10-K Report - TradingView
MeiraGTx earnings beat by $0.08, revenue topped estimates - Investing.com UK
MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson's Candidate, Stock Soars - Benzinga India
MeiraGTx (MGTX) Stock Climbs in Pre-Hour Trading - Stocks Telegraph
MeiraGTx secures $200 million, forms joint venture for CNS drugs By Investing.com - Investing.com Australia
MeiraGTx Secures $200 Mln From Hologen For Phase 3 Dvpt. Of AAV-GAD, Establish Neuro-AI JV - Nasdaq
MeiraGTx Holdings PLC reports results for the quarter ended December 31Earnings Summary - TradingView
MeiraGTx Holdings Announces Joint Venture with Hologen - TipRanks
MeiraGTx secures $200 million, forms joint venture for CNS drugs - Investing.com
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates - The Manila Times
MeiraGTx stock surges on Hologen AI deal By Investing.com - Investing.com South Africa
MeiraGTx stock surges on Hologen AI deal - Investing.com India
MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson's Disease and Industrialize MeiraGTx's Proprietary Manufacturing Process - The Manila Times
MeiraGTx and Hologen Limited Announce $200 Million Collaboration and Formation of Hologen Neuro AI Ltd Joint Venture for Parkinson's Disease Development - Nasdaq
Piper Sandler maintains Overweight on MeiraGTx stock, $26 target By Investing.com - Investing.com South Africa
Piper Sandler maintains Overweight on MeiraGTx stock, $26 target - Investing.com India
MeiraGTx Holdings PLC expected to post a loss of 56 cents a shareEarnings Preview - TradingView
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Purchased by Rhumbline Advisers - Defense World
MeiraGTx (MGTX) Projected to Post Quarterly Earnings on Thursday - Defense World
(MGTX) Investment Analysis - Stock Traders Daily
2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies - GlobeNewswire Inc.
MeiraGTx (NASDAQ:MGTX) Receives "Buy" Rating from Chardan Capital - MarketBeat
MeiraGTx Holdings plc (MGTX) expanding its growth trajectory ahead - SETE News
MeiraGTx’s (MGTX) Buy Rating Reaffirmed at Chardan Capital - Defense World
MeiraGTx seeks UK approval after gene therapy restores sight in children born blind - Yahoo Finance
MeiraGTx (NASDAQ:MGTX) Reaches New 52-Week High – What’s Next? - Defense World
3.01%
大文字化:
|
ボリューム (24 時間):